Cure8 research brief
This study reports a non-invasive fluorescence probe that detects a reactive nitrogen species (peroxynitrite) linked to intestinal inflammation and shows signal changes in cells, animal models, and mouse feces — a possible path toward earlier, less-invasive IBD monitoring and for evaluating treatments.
Researchers working on IBD biomarkers and diagnostics; translational clinicians interested in non-invasive monitoring tools; groups studying herbal or small-molecule anti-enteritis candidates.
Researchers describe a near-infrared fluorescent probe (HCY-PO) that detects peroxynitrite (ONOO-) and produces a strong signal within seconds. In mouse and zebrafish models and inflamed human cell lines, the probe tracked ONOO- changes and produced signals that correlated with disease severity.
The team tested the probe on mouse feces and used it as part of an integrated fluorescence sensing platform to semi-quantitatively evaluate the traditional Chinese medicine formula Bu-Zhong-Yi-Qi-Tang.
The platform's fluorescence results aligned with pathology and inflammatory marker tests, and the authors report screening five putative anti-enteritis bioactive compounds from the formula. This work is presented as an analytical tool study (probe development and preclinical testing) rather than a clinical diagnostic ready for human use.
Additional validation, standardization, and clinical studies would be required before this method could be used for patient diagnosis or routine monitoring.
Structured content depth: abstract — the summary and findings are drawn from the article abstract and preclinical experiments reported there. This is preclinical/basic-science work (cell and animal models and fecal testing in mice); it does not report clinical validation in humans.
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
The study describes a new urine-based fluorescent biosensor that detected inflamed intestinal sites and tracked treatment response earlier and more sensitively than fecal calprotectin in a mouse model of IBD, which could...
Non-invasive urine biomarkers could make diagnosis and disease-activity monitoring easier and less invasive for people with IBD. Identifying metabolites linked to UC activity may help tailor monitoring without frequent...
A wearable sensor that reliably measures inflammation markers (CRP and calprotectin) from sweat could make inflammation monitoring less invasive and more frequent for people with IBD, potentially helping detect flares...
